The Nomination Committee of Peptonic Medical AB (publ) presents the following proposals for resolutions at the Annual General Meeting on May 24 2023, regarding the number of members and election of board members.
Jan Bardell has declined re-election. The Nomination Committee proposes the election of Anna Stinger and Tarek Shoeb and the re-election of Anders Blom, Anders Norling and Daniel Rudeklint. The Nomination Committee proposes that Anders Blom is to be elected Chairman of the Board.
Anna Stinger, born 1968. CEO Anna Stinger AB. Anna Stinger is chairperson for Missing People Sweden. Previous assignments include Marketing Director Åhléns AB, acting Vice President Strategic Marketing Q-Med AB, Head of Global Marketing Q-Med AB and Head of Brand and Communication Tele2 AB. Anna Stinger has studied Strategic Business Communication at IHM Business School and Project Management at Berghs School of Communication. Anna Stinger is independent in relation to Peptonic Medical and its management and independent in relation to larger shareholders. Holdings: 0
Tarek Shoeb, born 1969. Tarek Shoeb is a board member of Terranet AB. Previous assignments include employments with Goldman Sachs, One Equity Partners, and Cerberus. Tarek Shoeb has primarily worked with private equity investments. Tarek Shoeb holds B.A. from the American University in Cairo and an MBA from Harvard Business School. Tarek Shoeb is independent in relation to Peptonic Medical and its management and independent in relation to larger shareholders. Holdings: 44,000,000 ordinary shares, 33,000,000 warrants.
Information about board members proposed will be made public at www.peptonicmedical.se
The Nomination Committee’s other proposals will be published in the notice to the Annual General Meeting. The Annual General Meeting will be held on May 24th, 2023.
The members of the Nomination Committee are Julian Aleksov appointed by Maida Vale Capital, Hans Derninger, appointed by the Vidar Foundation and Heli Kurjanen.
For further information, please contact:
Hans Derninger, Chairman of the Nomination Committee, +46 722 48 72 00
ABOUT Peptonic Medical AB
Peptonic is a Swedish innovative biomedical company that conducts research, development and sales of medical treatments and lifestyle products in the field of women’s health. Peptonic has divided its operations into two business areas: “Medical Consumer” and “Lifestyle Consumer”. The business area “Medical Consumer” is based on clinically proven intimate self-care and constitutes the company’s main focus and is sold under the VagiVital brand. The “Lifestyle Consumer” business area consists of lifestyle products with a focus on sustainable menstrual products and is sold under the Lunette brand. The company was founded in 2009 and the stock has been traded since 2014 on Spotlight (www.spotlightstockmarket.com) in Stockholm
